Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Subsidiaries of the Oxford University spinout, OxStem Immuno and OxStem Beta, will draw on research from the institution.

Regenerative medicine spinout oxstem launches subsidiaries

OxStem Ltd, an Oxford University spinout developing regenerative medicine-based therapies, is launching two subsidiary companies to develop regenerative treatments for diabetes and chronic inflammation and wound healing.

Find out more (Oxford University Innovation website)